Answers are grounded in this paper and cite their sources.
Longitudinal evaluation compares cerebral microbleeds detected in-vivo and ex-vivo, suggesting links with cognitive impairment and amyloid pathology.
Motivation: Cerebral microbleeds (CMBs) are studied in research of aging in-vivo or ex-vivo to study associations with amyloid-related imaging abnormalities (ARIA) and neuropathologies. However, a systematic comparison of CMBs imaged in-vivo and ex-vivo has not been conducted. Goal(s): To compare CMBs imaged in-vivo and ex-vivo in the same older adults. Approach: Longitudinal clinical evaluation, in-vivo MRI, ex-vivo MRI and detailed neuropathologic evaluation were combined in 37 community-based older adults. Results: Most CMBs were detected both in-vivo and ex-vivo. Ex-vivo CMB counts were higher than in-vivo with higher antemortem intervals. Participants with cognitive impairment or cerebral amyloid angiopathy have a higher odd of developing CMBs. Impact: We demonstrated that cerebral microbleeds (CMB) detected in-vivo were also detected ex-vivo. Also, cognitive impairment and cerebral amyloid angiopathy were associated with higher risk of CMB occurrence prior to death in older adults.
No takes yet. Share an insight, caveat, or question.
Yasar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: